TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 16, 2022

Primary Completion Date

September 10, 2024

Study Completion Date

September 10, 2024

Conditions
Digital Nerve Injury
Interventions
DEVICE

TISSIUM™ Nerve Coaptation Device

Placement of the TISSIUM™ Nerve Coaptation Device on repair site to achieve an end-to-end nerve coaptation.

Trial Locations (2)

4102

Princess Alexandra Hospital, Brisbane

4215

Gold Coast University Hospital, Gold Coast

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Tissium

INDUSTRY

NCT04327154 - TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial | Biotech Hunter | Biotech Hunter